Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Increased serum IL-17A and Th2 cytokine levels in patients with severe uncontrolled asthma

Increased serum IL-17A and Th2 cytokine levels in patients with severe uncontrolled asthma doi: 10.1684/ecn.2017.0390 Journal Identification = ECN Article Identification = 0390 Date: May 31, 2017 Time: 10:58 am 8 Eur. Cytokine Netw. Vol. 28 n 1, March 2017, 8-18 RESEARCH ARTICLE Increased serum IL-17A and Th2 cytokine levels in patients with severe uncontrolled asthma 1,2 1 3 1, 2 Takehiro Hasegawa , Hitoshi Uga , Akio Mori , Hirokazu Kurata Sysmex Corporation, Kobe, Japan Division of System Biology of Disease, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan Correspondence: H Kurata, Sysmex Corporation, Hematology Product Engineering, 4-4-4 Takatsukadai, Nishi-Ku, Kobe 651-2271, Japan <Kurata.Hirokazu@sysmex.co.jp> Accepted for publication February 22, 2017 To cite this article: Hasegawa T, Uga H, Mori A, Kurata H. Increased serum IL-17A and Th2 cytokine levels in patients with severe uncontrolled asthma. Eur. Cytokine Netw. 2017; 28(1): 8-18 doi:10.1684/ecn.2017.0390 ABSTRACT. Asthma is a syndrome of chronic bronchial inflammation and airway remodelling. Initially, asthma has been categorized into atopic and nonatopic types, based on antigen-specific IgE levels. Moreover, recently, asthma has been classified into different endotypes based on its pathophysiology, leading to the selection of the most optimal and effective therapies. Although T http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Cytokine Network Springer Journals

Increased serum IL-17A and Th2 cytokine levels in patients with severe uncontrolled asthma

Loading next page...
 
/lp/springer-journals/increased-serum-il-17a-and-th2-cytokine-levels-in-patients-with-severe-wygaNKMuWU
ISSN
1148-5493
eISSN
1148-5493
DOI
10.1684/ecn.2017.0390
Publisher site
See Article on Publisher Site

Abstract

doi: 10.1684/ecn.2017.0390 Journal Identification = ECN Article Identification = 0390 Date: May 31, 2017 Time: 10:58 am 8 Eur. Cytokine Netw. Vol. 28 n 1, March 2017, 8-18 RESEARCH ARTICLE Increased serum IL-17A and Th2 cytokine levels in patients with severe uncontrolled asthma 1,2 1 3 1, 2 Takehiro Hasegawa , Hitoshi Uga , Akio Mori , Hirokazu Kurata Sysmex Corporation, Kobe, Japan Division of System Biology of Disease, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan Correspondence: H Kurata, Sysmex Corporation, Hematology Product Engineering, 4-4-4 Takatsukadai, Nishi-Ku, Kobe 651-2271, Japan <Kurata.Hirokazu@sysmex.co.jp> Accepted for publication February 22, 2017 To cite this article: Hasegawa T, Uga H, Mori A, Kurata H. Increased serum IL-17A and Th2 cytokine levels in patients with severe uncontrolled asthma. Eur. Cytokine Netw. 2017; 28(1): 8-18 doi:10.1684/ecn.2017.0390 ABSTRACT. Asthma is a syndrome of chronic bronchial inflammation and airway remodelling. Initially, asthma has been categorized into atopic and nonatopic types, based on antigen-specific IgE levels. Moreover, recently, asthma has been classified into different endotypes based on its pathophysiology, leading to the selection of the most optimal and effective therapies. Although T

Journal

European Cytokine NetworkSpringer Journals

Published: Mar 1, 2017

There are no references for this article.